Katherine Vaidya, Senjuti Karmaker, Natalie Boehnke, Samira M. Azarin
{"title":"Modular Chemical Barcodes Enable Pooled Screening of Multimaterial Nanoparticle Libraries via GC−MS Quantitation","authors":"Katherine Vaidya, Senjuti Karmaker, Natalie Boehnke, Samira M. Azarin","doi":"10.1021/acs.molpharmaceut.6c00526","DOIUrl":null,"url":null,"abstract":"<p>Nanoparticle barcoding is a powerful approach to accelerate preclinical screening of nanotherapeutics by enabling rapid collection of high-volume data using fewer biological resources, with reduced experimental labor and fewer confounding variables across experiments. We previously introduced aryl halide-based tags (halocodes) as a barcoding technology with sensitive gas chromatography−mass spectrometry (GC−MS) detection, enabling nanoparticle tracking with minimal halocode incorporation and without measurably altering nanoparticle physicochemical properties. Building on this foundation, in this work, we developed a next generation of alkoxy-modified halocodes with tunable chemical properties that enhance encapsulation and stability within nanomaterials and extend the halocoding platform to lipid-based systems. By systematically varying halocode chemical structure and nanoparticle synthesis parameters, we established design rules governing halocode loading and retention in both polymeric nanoparticles and liposomes. We then leveraged next generation halocodes to perform a pooled in vitro screen of a mixed-core PLGA and liposomal-based nanoparticle library to identify nanoparticle core and surface chemistries with the highest affinity for ovarian cancer cells. Together, next generation halocodes provide a more modular and broadly compatible barcoding toolkit that simplifies pooled screening and supports quantitative evaluation of diverse nanocarrier libraries across biological settings.</p>","PeriodicalId":52,"journal":{"name":"Molecular Pharmaceutics","volume":"23 10","pages":"4935–4948"},"PeriodicalIF":4.9000,"publicationDate":"2026-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Pharmaceutics","FirstCategoryId":"3","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acs.molpharmaceut.6c00526","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/9/4 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
Abstract
Nanoparticle barcoding is a powerful approach to accelerate preclinical screening of nanotherapeutics by enabling rapid collection of high-volume data using fewer biological resources, with reduced experimental labor and fewer confounding variables across experiments. We previously introduced aryl halide-based tags (halocodes) as a barcoding technology with sensitive gas chromatography−mass spectrometry (GC−MS) detection, enabling nanoparticle tracking with minimal halocode incorporation and without measurably altering nanoparticle physicochemical properties. Building on this foundation, in this work, we developed a next generation of alkoxy-modified halocodes with tunable chemical properties that enhance encapsulation and stability within nanomaterials and extend the halocoding platform to lipid-based systems. By systematically varying halocode chemical structure and nanoparticle synthesis parameters, we established design rules governing halocode loading and retention in both polymeric nanoparticles and liposomes. We then leveraged next generation halocodes to perform a pooled in vitro screen of a mixed-core PLGA and liposomal-based nanoparticle library to identify nanoparticle core and surface chemistries with the highest affinity for ovarian cancer cells. Together, next generation halocodes provide a more modular and broadly compatible barcoding toolkit that simplifies pooled screening and supports quantitative evaluation of diverse nanocarrier libraries across biological settings.
期刊介绍:
Molecular Pharmaceutics publishes the results of original research that contributes significantly to the molecular mechanistic understanding of drug delivery and drug delivery systems. The journal encourages contributions describing research at the interface of drug discovery and drug development.
Scientific areas within the scope of the journal include physical and pharmaceutical chemistry, biochemistry and biophysics, molecular and cellular biology, and polymer and materials science as they relate to drug and drug delivery system efficacy. Mechanistic Drug Delivery and Drug Targeting research on modulating activity and efficacy of a drug or drug product is within the scope of Molecular Pharmaceutics. Theoretical and experimental peer-reviewed research articles, communications, reviews, and perspectives are welcomed.